Cholera vaccine CVD 111Alternative Names: CVD 111
Latest Information Update: 21 Jun 1999
At a glance
- Originator Center for Vaccine Development
- Class Cholera vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cholera
Most Recent Events
- 21 Jun 1999 Discontinued-I for Cholera in USA (PO)
- 17 Jun 1997 New profile
- 17 Jun 1997 Phase-I clinical trials for Cholera in USA (PO)